Cargando…
The Hippo signaling pathway: a potential therapeutic target is reversed by a Chinese patent drug in rats with diabetic retinopathy
BACKGROUND: The Hippo signaling pathway is reported to be involved in angiogenesis, but the roles of the Hippo pathway in diabetic retinopathy have not been addressed. Fufang Xueshuantong Capsule has been used to treat diabetic retinopathy in China; however, the effect of Fufang Xueshuantong Capsule...
Autores principales: | Hao, Gai-mei, Lv, Tian-tian, Wu, Yan, Wang, Hong-liang, Xing, Wei, Wang, Yong, Li, Chun, Zhang, Zi-jian, Wang, Zheng-lin, Wang, Wei, Han, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379696/ https://www.ncbi.nlm.nih.gov/pubmed/28372586 http://dx.doi.org/10.1186/s12906-017-1678-3 |
Ejemplares similares
-
The Hippo pathway in endometrial cancer: a potential therapeutic target?
por: Shen, Xinyun, et al.
Publicado: (2023) -
Advances in prognostic and therapeutic targets for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The hippo signaling pathway
por: Mranda, Geofrey Mahiki, et al.
Publicado: (2022) -
Diabetic retinopathy: reversibility of epigenetic modifications and new therapeutic targets
por: Zhang, Xinyuan, et al.
Publicado: (2017) -
Scope of claim coverage in patents of fufang Chinese herbal drugs: Substitution of ingredients
por: Wang, Xinsheng, et al.
Publicado: (2011) -
CPMCP: a database of Chinese patent medicine and compound prescription
por: Sun, Chang, et al.
Publicado: (2022)